nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.222	0.5	CpDpCtD
Rasagiline—Parkinson's disease—Memantine—Alzheimer's disease	0.222	0.5	CpDpCtD
Rasagiline—BCL2—Alzheimer's disease	0.205	0.533	CbGaD
Rasagiline—MAOB—Alzheimer's disease	0.179	0.467	CbGaD
Rasagiline—BCL2—forebrain—Alzheimer's disease	0.00104	0.182	CbGeAlD
Rasagiline—BCL2—telencephalon—Alzheimer's disease	0.000955	0.167	CbGeAlD
Rasagiline—BCL2—nervous system—Alzheimer's disease	0.000564	0.0987	CbGeAlD
Rasagiline—BCL2—central nervous system—Alzheimer's disease	0.000543	0.095	CbGeAlD
Rasagiline—MAOB—embryo—Alzheimer's disease	0.000489	0.0856	CbGeAlD
Rasagiline—MAOB—forebrain—Alzheimer's disease	0.000432	0.0757	CbGeAlD
Rasagiline—BCL2—brain—Alzheimer's disease	0.000431	0.0754	CbGeAlD
Rasagiline—MAOB—telencephalon—Alzheimer's disease	0.000398	0.0696	CbGeAlD
Rasagiline—MAOB—nervous system—Alzheimer's disease	0.000235	0.0411	CbGeAlD
Rasagiline—MAOB—central nervous system—Alzheimer's disease	0.000226	0.0396	CbGeAlD
Rasagiline—MAOB—cerebellum—Alzheimer's disease	0.000221	0.0387	CbGeAlD
Rasagiline—MAOB—brain—Alzheimer's disease	0.000179	0.0314	CbGeAlD
Rasagiline—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00012	0.00105	CcSEcCtD
Rasagiline—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00012	0.00105	CcSEcCtD
Rasagiline—Infestation—Rivastigmine—Alzheimer's disease	0.00012	0.00105	CcSEcCtD
Rasagiline—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000119	0.00105	CcSEcCtD
Rasagiline—Loss of consciousness—Galantamine—Alzheimer's disease	0.000119	0.00105	CcSEcCtD
Rasagiline—Depression—Rivastigmine—Alzheimer's disease	0.000119	0.00104	CcSEcCtD
Rasagiline—Oedema peripheral—Donepezil—Alzheimer's disease	0.000119	0.00104	CcSEcCtD
Rasagiline—Conjunctivitis—Memantine—Alzheimer's disease	0.000119	0.00104	CcSEcCtD
Rasagiline—Urethral disorder—Donepezil—Alzheimer's disease	0.000119	0.00104	CcSEcCtD
Rasagiline—Cough—Galantamine—Alzheimer's disease	0.000119	0.00104	CcSEcCtD
Rasagiline—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000118	0.00103	CcSEcCtD
Rasagiline—Convulsion—Galantamine—Alzheimer's disease	0.000118	0.00103	CcSEcCtD
Rasagiline—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000117	0.00103	CcSEcCtD
Rasagiline—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000117	0.00103	CcSEcCtD
Rasagiline—Hypertension—Galantamine—Alzheimer's disease	0.000117	0.00103	CcSEcCtD
Rasagiline—Haematuria—Memantine—Alzheimer's disease	0.000117	0.00102	CcSEcCtD
Rasagiline—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000116	0.00102	CcSEcCtD
Rasagiline—Chest pain—Galantamine—Alzheimer's disease	0.000116	0.00101	CcSEcCtD
Rasagiline—Arthralgia—Galantamine—Alzheimer's disease	0.000116	0.00101	CcSEcCtD
Rasagiline—Epistaxis—Memantine—Alzheimer's disease	0.000115	0.00101	CcSEcCtD
Rasagiline—Anxiety—Galantamine—Alzheimer's disease	0.000115	0.00101	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000115	0.00101	CcSEcCtD
Rasagiline—Sweating—Rivastigmine—Alzheimer's disease	0.000115	0.001	CcSEcCtD
Rasagiline—Discomfort—Galantamine—Alzheimer's disease	0.000114	0.001	CcSEcCtD
Rasagiline—Haematuria—Rivastigmine—Alzheimer's disease	0.000114	0.000999	CcSEcCtD
Rasagiline—Dry mouth—Galantamine—Alzheimer's disease	0.000113	0.00099	CcSEcCtD
Rasagiline—Epistaxis—Rivastigmine—Alzheimer's disease	0.000113	0.000988	CcSEcCtD
Rasagiline—Confusional state—Galantamine—Alzheimer's disease	0.000112	0.000979	CcSEcCtD
Rasagiline—Haemoglobin—Memantine—Alzheimer's disease	0.00011	0.000966	CcSEcCtD
Rasagiline—Rhinitis—Memantine—Alzheimer's disease	0.00011	0.000964	CcSEcCtD
Rasagiline—Haemorrhage—Memantine—Alzheimer's disease	0.00011	0.000961	CcSEcCtD
Rasagiline—Hypoaesthesia—Memantine—Alzheimer's disease	0.000109	0.000957	CcSEcCtD
Rasagiline—Hallucination—Memantine—Alzheimer's disease	0.000109	0.000957	CcSEcCtD
Rasagiline—Shock—Galantamine—Alzheimer's disease	0.000109	0.000955	CcSEcCtD
Rasagiline—Nervous system disorder—Galantamine—Alzheimer's disease	0.000109	0.000952	CcSEcCtD
Rasagiline—Chills—Donepezil—Alzheimer's disease	0.000109	0.00095	CcSEcCtD
Rasagiline—Urinary tract disorder—Memantine—Alzheimer's disease	0.000108	0.000949	CcSEcCtD
Rasagiline—Oedema peripheral—Memantine—Alzheimer's disease	0.000108	0.000947	CcSEcCtD
Rasagiline—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000108	0.000945	CcSEcCtD
Rasagiline—Connective tissue disorder—Memantine—Alzheimer's disease	0.000108	0.000945	CcSEcCtD
Rasagiline—Rhinitis—Rivastigmine—Alzheimer's disease	0.000108	0.000943	CcSEcCtD
Rasagiline—Skin disorder—Galantamine—Alzheimer's disease	0.000108	0.000943	CcSEcCtD
Rasagiline—Urethral disorder—Memantine—Alzheimer's disease	0.000108	0.000942	CcSEcCtD
Rasagiline—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000107	0.000941	CcSEcCtD
Rasagiline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000107	0.000938	CcSEcCtD
Rasagiline—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000107	0.000936	CcSEcCtD
Rasagiline—Hallucination—Rivastigmine—Alzheimer's disease	0.000107	0.000936	CcSEcCtD
Rasagiline—Alopecia—Donepezil—Alzheimer's disease	0.000107	0.000936	CcSEcCtD
Rasagiline—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000106	0.000929	CcSEcCtD
Rasagiline—Mental disorder—Donepezil—Alzheimer's disease	0.000106	0.000928	CcSEcCtD
Rasagiline—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000106	0.000927	CcSEcCtD
Rasagiline—Anorexia—Galantamine—Alzheimer's disease	0.000106	0.000925	CcSEcCtD
Rasagiline—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000106	0.000924	CcSEcCtD
Rasagiline—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000105	0.000922	CcSEcCtD
Rasagiline—Malnutrition—Donepezil—Alzheimer's disease	0.000105	0.000922	CcSEcCtD
Rasagiline—Flatulence—Donepezil—Alzheimer's disease	0.000104	0.000908	CcSEcCtD
Rasagiline—Hypotension—Galantamine—Alzheimer's disease	0.000104	0.000907	CcSEcCtD
Rasagiline—Dysgeusia—Donepezil—Alzheimer's disease	0.000103	0.000903	CcSEcCtD
Rasagiline—Eye disorder—Memantine—Alzheimer's disease	0.000103	0.000898	CcSEcCtD
Rasagiline—Cardiac disorder—Memantine—Alzheimer's disease	0.000102	0.000892	CcSEcCtD
Rasagiline—Back pain—Donepezil—Alzheimer's disease	0.000102	0.000892	CcSEcCtD
Rasagiline—Muscle spasms—Donepezil—Alzheimer's disease	0.000101	0.000886	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000101	0.000884	CcSEcCtD
Rasagiline—Eye disorder—Rivastigmine—Alzheimer's disease	0.0001	0.000879	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.0001	0.00192	CbGpPWpGaD
Rasagiline—Insomnia—Galantamine—Alzheimer's disease	0.0001	0.000878	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—Alzheimer's disease	0.0001	0.00191	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—MAPK8—Alzheimer's disease	9.98e-05	0.00191	CbGpPWpGaD
Rasagiline—Cardiac disorder—Rivastigmine—Alzheimer's disease	9.97e-05	0.000873	CcSEcCtD
Rasagiline—Angiopathy—Memantine—Alzheimer's disease	9.97e-05	0.000872	CcSEcCtD
Rasagiline—Paraesthesia—Galantamine—Alzheimer's disease	9.96e-05	0.000872	CcSEcCtD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—CASP3—Alzheimer's disease	9.94e-05	0.0019	CbGpPWpGaD
Rasagiline—Immune system disorder—Memantine—Alzheimer's disease	9.92e-05	0.000868	CcSEcCtD
Rasagiline—Mediastinal disorder—Memantine—Alzheimer's disease	9.9e-05	0.000866	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	9.87e-05	0.00189	CbGpPWpGaD
Rasagiline—Tremor—Donepezil—Alzheimer's disease	9.87e-05	0.000864	CcSEcCtD
Rasagiline—Somnolence—Galantamine—Alzheimer's disease	9.86e-05	0.000863	CcSEcCtD
Rasagiline—Chills—Memantine—Alzheimer's disease	9.86e-05	0.000863	CcSEcCtD
Rasagiline—Ill-defined disorder—Donepezil—Alzheimer's disease	9.77e-05	0.000855	CcSEcCtD
Rasagiline—Dyspepsia—Galantamine—Alzheimer's disease	9.76e-05	0.000854	CcSEcCtD
Rasagiline—Angiopathy—Rivastigmine—Alzheimer's disease	9.75e-05	0.000853	CcSEcCtD
Rasagiline—Anaemia—Donepezil—Alzheimer's disease	9.73e-05	0.000852	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—PLAU—Alzheimer's disease	9.72e-05	0.00186	CbGpPWpGaD
Rasagiline—Alopecia—Memantine—Alzheimer's disease	9.71e-05	0.00085	CcSEcCtD
Rasagiline—Mediastinal disorder—Rivastigmine—Alzheimer's disease	9.68e-05	0.000848	CcSEcCtD
Rasagiline—Agitation—Donepezil—Alzheimer's disease	9.68e-05	0.000847	CcSEcCtD
Rasagiline—Chills—Rivastigmine—Alzheimer's disease	9.64e-05	0.000844	CcSEcCtD
Rasagiline—Decreased appetite—Galantamine—Alzheimer's disease	9.64e-05	0.000844	CcSEcCtD
Rasagiline—Mental disorder—Memantine—Alzheimer's disease	9.62e-05	0.000842	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Galantamine—Alzheimer's disease	9.57e-05	0.000838	CcSEcCtD
Rasagiline—Malnutrition—Memantine—Alzheimer's disease	9.56e-05	0.000837	CcSEcCtD
Rasagiline—BCL2—IL2-mediated signaling events—MAPK8—Alzheimer's disease	9.54e-05	0.00182	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MAPK8—Alzheimer's disease	9.54e-05	0.00182	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—TGFB1—Alzheimer's disease	9.52e-05	0.00182	CbGpPWpGaD
Rasagiline—Malaise—Donepezil—Alzheimer's disease	9.5e-05	0.000831	CcSEcCtD
Rasagiline—BCL2—Immune System—NCR2—Alzheimer's disease	9.5e-05	0.00181	CbGpPWpGaD
Rasagiline—Alopecia—Rivastigmine—Alzheimer's disease	9.49e-05	0.000831	CcSEcCtD
Rasagiline—Constipation—Galantamine—Alzheimer's disease	9.48e-05	0.00083	CcSEcCtD
Rasagiline—BCL2—Apoptosis—IGF1—Alzheimer's disease	9.47e-05	0.00181	CbGpPWpGaD
Rasagiline—Vertigo—Donepezil—Alzheimer's disease	9.46e-05	0.000828	CcSEcCtD
Rasagiline—Syncope—Donepezil—Alzheimer's disease	9.44e-05	0.000827	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PLAU—Alzheimer's disease	9.43e-05	0.0018	CbGpPWpGaD
Rasagiline—Flatulence—Memantine—Alzheimer's disease	9.42e-05	0.000825	CcSEcCtD
Rasagiline—Mental disorder—Rivastigmine—Alzheimer's disease	9.41e-05	0.000824	CcSEcCtD
Rasagiline—Dysgeusia—Memantine—Alzheimer's disease	9.36e-05	0.00082	CcSEcCtD
Rasagiline—Malnutrition—Rivastigmine—Alzheimer's disease	9.35e-05	0.000819	CcSEcCtD
Rasagiline—Loss of consciousness—Donepezil—Alzheimer's disease	9.26e-05	0.00081	CcSEcCtD
Rasagiline—Back pain—Memantine—Alzheimer's disease	9.25e-05	0.00081	CcSEcCtD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—Alzheimer's disease	9.23e-05	0.00176	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—GSK3B—Alzheimer's disease	9.22e-05	0.00176	CbGpPWpGaD
Rasagiline—Flatulence—Rivastigmine—Alzheimer's disease	9.22e-05	0.000807	CcSEcCtD
Rasagiline—Cough—Donepezil—Alzheimer's disease	9.19e-05	0.000804	CcSEcCtD
Rasagiline—Dysgeusia—Rivastigmine—Alzheimer's disease	9.16e-05	0.000802	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—CREB1—Alzheimer's disease	9.15e-05	0.00175	CbGpPWpGaD
Rasagiline—Feeling abnormal—Galantamine—Alzheimer's disease	9.14e-05	0.0008	CcSEcCtD
Rasagiline—Convulsion—Donepezil—Alzheimer's disease	9.12e-05	0.000799	CcSEcCtD
Rasagiline—Hypertension—Donepezil—Alzheimer's disease	9.09e-05	0.000796	CcSEcCtD
Rasagiline—Gastrointestinal pain—Galantamine—Alzheimer's disease	9.07e-05	0.000794	CcSEcCtD
Rasagiline—Back pain—Rivastigmine—Alzheimer's disease	9.05e-05	0.000792	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—BAX—Alzheimer's disease	9.02e-05	0.00172	CbGpPWpGaD
Rasagiline—Muscle spasms—Rivastigmine—Alzheimer's disease	8.99e-05	0.000787	CcSEcCtD
Rasagiline—Chest pain—Donepezil—Alzheimer's disease	8.97e-05	0.000785	CcSEcCtD
Rasagiline—Arthralgia—Donepezil—Alzheimer's disease	8.97e-05	0.000785	CcSEcCtD
Rasagiline—Tremor—Memantine—Alzheimer's disease	8.96e-05	0.000784	CcSEcCtD
Rasagiline—Anxiety—Donepezil—Alzheimer's disease	8.93e-05	0.000782	CcSEcCtD
Rasagiline—BCL2—Kit receptor signaling pathway—MAPK8—Alzheimer's disease	8.88e-05	0.0017	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—MAPK8—Alzheimer's disease	8.88e-05	0.0017	CbGpPWpGaD
Rasagiline—Ill-defined disorder—Memantine—Alzheimer's disease	8.87e-05	0.000777	CcSEcCtD
Rasagiline—Discomfort—Donepezil—Alzheimer's disease	8.86e-05	0.000775	CcSEcCtD
Rasagiline—Anaemia—Memantine—Alzheimer's disease	8.84e-05	0.000774	CcSEcCtD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—Alzheimer's disease	8.81e-05	0.00168	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—Alzheimer's disease	8.81e-05	0.00168	CbGpPWpGaD
Rasagiline—Agitation—Memantine—Alzheimer's disease	8.79e-05	0.000769	CcSEcCtD
Rasagiline—Dry mouth—Donepezil—Alzheimer's disease	8.77e-05	0.000767	CcSEcCtD
Rasagiline—Abdominal pain—Galantamine—Alzheimer's disease	8.77e-05	0.000767	CcSEcCtD
Rasagiline—Body temperature increased—Galantamine—Alzheimer's disease	8.77e-05	0.000767	CcSEcCtD
Rasagiline—Tremor—Rivastigmine—Alzheimer's disease	8.76e-05	0.000767	CcSEcCtD
Rasagiline—BCL2—IL-3 Signaling Pathway—TGFB1—Alzheimer's disease	8.73e-05	0.00167	CbGpPWpGaD
Rasagiline—Ill-defined disorder—Rivastigmine—Alzheimer's disease	8.68e-05	0.00076	CcSEcCtD
Rasagiline—Confusional state—Donepezil—Alzheimer's disease	8.67e-05	0.000759	CcSEcCtD
Rasagiline—Anaemia—Rivastigmine—Alzheimer's disease	8.65e-05	0.000757	CcSEcCtD
Rasagiline—Malaise—Memantine—Alzheimer's disease	8.62e-05	0.000755	CcSEcCtD
Rasagiline—Agitation—Rivastigmine—Alzheimer's disease	8.6e-05	0.000752	CcSEcCtD
Rasagiline—Vertigo—Memantine—Alzheimer's disease	8.59e-05	0.000752	CcSEcCtD
Rasagiline—Syncope—Memantine—Alzheimer's disease	8.57e-05	0.000751	CcSEcCtD
Rasagiline—Leukopenia—Memantine—Alzheimer's disease	8.56e-05	0.000749	CcSEcCtD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	8.55e-05	0.00163	CbGpPWpGaD
Rasagiline—Infection—Donepezil—Alzheimer's disease	8.54e-05	0.000747	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	8.49e-05	0.00162	CbGpPWpGaD
Rasagiline—BCL2—Immune System—BLMH—Alzheimer's disease	8.46e-05	0.00162	CbGpPWpGaD
Rasagiline—Shock—Donepezil—Alzheimer's disease	8.46e-05	0.00074	CcSEcCtD
Rasagiline—Malaise—Rivastigmine—Alzheimer's disease	8.44e-05	0.000738	CcSEcCtD
Rasagiline—Nervous system disorder—Donepezil—Alzheimer's disease	8.43e-05	0.000738	CcSEcCtD
Rasagiline—Vertigo—Rivastigmine—Alzheimer's disease	8.4e-05	0.000736	CcSEcCtD
Rasagiline—Loss of consciousness—Memantine—Alzheimer's disease	8.4e-05	0.000736	CcSEcCtD
Rasagiline—Syncope—Rivastigmine—Alzheimer's disease	8.39e-05	0.000734	CcSEcCtD
Rasagiline—Cough—Memantine—Alzheimer's disease	8.34e-05	0.00073	CcSEcCtD
Rasagiline—BCL2—Apoptosis—BAX—Alzheimer's disease	8.31e-05	0.00159	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Donepezil—Alzheimer's disease	8.31e-05	0.000727	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—GSK3B—Alzheimer's disease	8.3e-05	0.00159	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—Alzheimer's disease	8.29e-05	0.00158	CbGpPWpGaD
Rasagiline—Convulsion—Memantine—Alzheimer's disease	8.28e-05	0.000725	CcSEcCtD
Rasagiline—Hypertension—Memantine—Alzheimer's disease	8.25e-05	0.000723	CcSEcCtD
Rasagiline—Loss of consciousness—Rivastigmine—Alzheimer's disease	8.22e-05	0.00072	CcSEcCtD
Rasagiline—Anorexia—Donepezil—Alzheimer's disease	8.19e-05	0.000717	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—INS—Alzheimer's disease	8.19e-05	0.00156	CbGpPWpGaD
Rasagiline—Hypersensitivity—Galantamine—Alzheimer's disease	8.17e-05	0.000715	CcSEcCtD
Rasagiline—Cough—Rivastigmine—Alzheimer's disease	8.16e-05	0.000714	CcSEcCtD
Rasagiline—Arthralgia—Memantine—Alzheimer's disease	8.14e-05	0.000713	CcSEcCtD
Rasagiline—Chest pain—Memantine—Alzheimer's disease	8.14e-05	0.000713	CcSEcCtD
Rasagiline—Anxiety—Memantine—Alzheimer's disease	8.11e-05	0.00071	CcSEcCtD
Rasagiline—Convulsion—Rivastigmine—Alzheimer's disease	8.1e-05	0.000709	CcSEcCtD
Rasagiline—Hypertension—Rivastigmine—Alzheimer's disease	8.08e-05	0.000707	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—GSK3B—Alzheimer's disease	8.05e-05	0.00154	CbGpPWpGaD
Rasagiline—Discomfort—Memantine—Alzheimer's disease	8.04e-05	0.000704	CcSEcCtD
Rasagiline—Hypotension—Donepezil—Alzheimer's disease	8.03e-05	0.000703	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—NOS3—Alzheimer's disease	7.98e-05	0.00152	CbGpPWpGaD
Rasagiline—Chest pain—Rivastigmine—Alzheimer's disease	7.96e-05	0.000697	CcSEcCtD
Rasagiline—Arthralgia—Rivastigmine—Alzheimer's disease	7.96e-05	0.000697	CcSEcCtD
Rasagiline—Dry mouth—Memantine—Alzheimer's disease	7.96e-05	0.000697	CcSEcCtD
Rasagiline—Asthenia—Galantamine—Alzheimer's disease	7.96e-05	0.000696	CcSEcCtD
Rasagiline—Anxiety—Rivastigmine—Alzheimer's disease	7.94e-05	0.000695	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IGF1—Alzheimer's disease	7.92e-05	0.00151	CbGpPWpGaD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	7.91e-05	0.000692	CcSEcCtD
Rasagiline—Confusional state—Memantine—Alzheimer's disease	7.87e-05	0.000689	CcSEcCtD
Rasagiline—Discomfort—Rivastigmine—Alzheimer's disease	7.87e-05	0.000689	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—PTGS2—Alzheimer's disease	7.85e-05	0.0015	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—Alzheimer's disease	7.84e-05	0.0015	CbGpPWpGaD
Rasagiline—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	7.83e-05	0.000685	CcSEcCtD
Rasagiline—Dry mouth—Rivastigmine—Alzheimer's disease	7.79e-05	0.000682	CcSEcCtD
Rasagiline—Insomnia—Donepezil—Alzheimer's disease	7.77e-05	0.00068	CcSEcCtD
Rasagiline—Infection—Memantine—Alzheimer's disease	7.75e-05	0.000679	CcSEcCtD
Rasagiline—Paraesthesia—Donepezil—Alzheimer's disease	7.72e-05	0.000676	CcSEcCtD
Rasagiline—Confusional state—Rivastigmine—Alzheimer's disease	7.7e-05	0.000674	CcSEcCtD
Rasagiline—Shock—Memantine—Alzheimer's disease	7.68e-05	0.000672	CcSEcCtD
Rasagiline—Dyspnoea—Donepezil—Alzheimer's disease	7.66e-05	0.000671	CcSEcCtD
Rasagiline—Nervous system disorder—Memantine—Alzheimer's disease	7.65e-05	0.00067	CcSEcCtD
Rasagiline—Somnolence—Donepezil—Alzheimer's disease	7.64e-05	0.000669	CcSEcCtD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—AKT1—Alzheimer's disease	7.6e-05	0.00145	CbGpPWpGaD
Rasagiline—Diarrhoea—Galantamine—Alzheimer's disease	7.59e-05	0.000664	CcSEcCtD
Rasagiline—Infection—Rivastigmine—Alzheimer's disease	7.58e-05	0.000664	CcSEcCtD
Rasagiline—Skin disorder—Memantine—Alzheimer's disease	7.58e-05	0.000663	CcSEcCtD
Rasagiline—Dyspepsia—Donepezil—Alzheimer's disease	7.57e-05	0.000662	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	7.56e-05	0.00144	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Memantine—Alzheimer's disease	7.54e-05	0.00066	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—CAV1—Alzheimer's disease	7.54e-05	0.00144	CbGpPWpGaD
Rasagiline—Shock—Rivastigmine—Alzheimer's disease	7.51e-05	0.000657	CcSEcCtD
Rasagiline—Nervous system disorder—Rivastigmine—Alzheimer's disease	7.49e-05	0.000655	CcSEcCtD
Rasagiline—Decreased appetite—Donepezil—Alzheimer's disease	7.47e-05	0.000654	CcSEcCtD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—AKT1—Alzheimer's disease	7.44e-05	0.00142	CbGpPWpGaD
Rasagiline—Anorexia—Memantine—Alzheimer's disease	7.44e-05	0.000651	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Donepezil—Alzheimer's disease	7.42e-05	0.000649	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—IGF1R—Alzheimer's disease	7.42e-05	0.00142	CbGpPWpGaD
Rasagiline—Skin disorder—Rivastigmine—Alzheimer's disease	7.42e-05	0.000649	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	7.39e-05	0.00141	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	7.38e-05	0.000646	CcSEcCtD
Rasagiline—Constipation—Donepezil—Alzheimer's disease	7.35e-05	0.000643	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—PIN1—Alzheimer's disease	7.35e-05	0.0014	CbGpPWpGaD
Rasagiline—Dizziness—Galantamine—Alzheimer's disease	7.33e-05	0.000642	CcSEcCtD
Rasagiline—Hypotension—Memantine—Alzheimer's disease	7.29e-05	0.000638	CcSEcCtD
Rasagiline—BCL2—Apoptosis—CASP3—Alzheimer's disease	7.29e-05	0.00139	CbGpPWpGaD
Rasagiline—Anorexia—Rivastigmine—Alzheimer's disease	7.28e-05	0.000637	CcSEcCtD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—Alzheimer's disease	7.23e-05	0.00138	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—AKT1—Alzheimer's disease	7.14e-05	0.00136	CbGpPWpGaD
Rasagiline—Hypotension—Rivastigmine—Alzheimer's disease	7.13e-05	0.000624	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Memantine—Alzheimer's disease	7.11e-05	0.000622	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CR1—Alzheimer's disease	7.1e-05	0.00136	CbGpPWpGaD
Rasagiline—Feeling abnormal—Donepezil—Alzheimer's disease	7.08e-05	0.00062	CcSEcCtD
Rasagiline—Insomnia—Memantine—Alzheimer's disease	7.06e-05	0.000618	CcSEcCtD
Rasagiline—Vomiting—Galantamine—Alzheimer's disease	7.05e-05	0.000617	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	7.03e-05	0.00134	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Donepezil—Alzheimer's disease	7.03e-05	0.000615	CcSEcCtD
Rasagiline—Paraesthesia—Memantine—Alzheimer's disease	7.01e-05	0.000613	CcSEcCtD
Rasagiline—Rash—Galantamine—Alzheimer's disease	6.99e-05	0.000612	CcSEcCtD
Rasagiline—Dermatitis—Galantamine—Alzheimer's disease	6.99e-05	0.000611	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CFH—Alzheimer's disease	6.98e-05	0.00133	CbGpPWpGaD
Rasagiline—Dyspnoea—Memantine—Alzheimer's disease	6.96e-05	0.000609	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	6.96e-05	0.000609	CcSEcCtD
Rasagiline—Headache—Galantamine—Alzheimer's disease	6.95e-05	0.000608	CcSEcCtD
Rasagiline—Somnolence—Memantine—Alzheimer's disease	6.94e-05	0.000607	CcSEcCtD
Rasagiline—Insomnia—Rivastigmine—Alzheimer's disease	6.9e-05	0.000604	CcSEcCtD
Rasagiline—Dyspepsia—Memantine—Alzheimer's disease	6.87e-05	0.000601	CcSEcCtD
Rasagiline—BCL2—IL-2 Signaling Pathway—AKT1—Alzheimer's disease	6.87e-05	0.00131	CbGpPWpGaD
Rasagiline—Paraesthesia—Rivastigmine—Alzheimer's disease	6.85e-05	0.0006	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	6.84e-05	0.00131	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CASP3—Alzheimer's disease	6.83e-05	0.00131	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	6.83e-05	0.00131	CbGpPWpGaD
Rasagiline—Urticaria—Donepezil—Alzheimer's disease	6.83e-05	0.000598	CcSEcCtD
Rasagiline—Dyspnoea—Rivastigmine—Alzheimer's disease	6.81e-05	0.000596	CcSEcCtD
Rasagiline—Body temperature increased—Donepezil—Alzheimer's disease	6.79e-05	0.000595	CcSEcCtD
Rasagiline—Abdominal pain—Donepezil—Alzheimer's disease	6.79e-05	0.000595	CcSEcCtD
Rasagiline—Somnolence—Rivastigmine—Alzheimer's disease	6.79e-05	0.000594	CcSEcCtD
Rasagiline—Decreased appetite—Memantine—Alzheimer's disease	6.78e-05	0.000594	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP3—Alzheimer's disease	6.77e-05	0.00129	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Memantine—Alzheimer's disease	6.74e-05	0.00059	CcSEcCtD
Rasagiline—MAOB—Metabolism—DHCR24—Alzheimer's disease	6.74e-05	0.00129	CbGpPWpGaD
Rasagiline—Dyspepsia—Rivastigmine—Alzheimer's disease	6.72e-05	0.000588	CcSEcCtD
Rasagiline—Constipation—Memantine—Alzheimer's disease	6.67e-05	0.000584	CcSEcCtD
Rasagiline—Decreased appetite—Rivastigmine—Alzheimer's disease	6.64e-05	0.000581	CcSEcCtD
Rasagiline—BCL2—Integrated Cancer Pathway—AKT1—Alzheimer's disease	6.62e-05	0.00126	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—AKT1—Alzheimer's disease	6.62e-05	0.00126	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	6.59e-05	0.000577	CcSEcCtD
Rasagiline—Nausea—Galantamine—Alzheimer's disease	6.59e-05	0.000577	CcSEcCtD
Rasagiline—Constipation—Rivastigmine—Alzheimer's disease	6.53e-05	0.000571	CcSEcCtD
Rasagiline—Feeling abnormal—Memantine—Alzheimer's disease	6.43e-05	0.000563	CcSEcCtD
Rasagiline—BCL2—Immune System—TREM2—Alzheimer's disease	6.41e-05	0.00123	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—CALM1—Alzheimer's disease	6.41e-05	0.00123	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—APOE—Alzheimer's disease	6.39e-05	0.00122	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Memantine—Alzheimer's disease	6.38e-05	0.000559	CcSEcCtD
Rasagiline—Hypersensitivity—Donepezil—Alzheimer's disease	6.33e-05	0.000554	CcSEcCtD
Rasagiline—Feeling abnormal—Rivastigmine—Alzheimer's disease	6.29e-05	0.000551	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—MAPK8—Alzheimer's disease	6.28e-05	0.0012	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	6.26e-05	0.0012	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	6.24e-05	0.000546	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—MAPK8—Alzheimer's disease	6.23e-05	0.00119	CbGpPWpGaD
Rasagiline—Urticaria—Memantine—Alzheimer's disease	6.2e-05	0.000543	CcSEcCtD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	6.18e-05	0.00118	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—AKT1—Alzheimer's disease	6.17e-05	0.00118	CbGpPWpGaD
Rasagiline—Body temperature increased—Memantine—Alzheimer's disease	6.17e-05	0.00054	CcSEcCtD
Rasagiline—Abdominal pain—Memantine—Alzheimer's disease	6.17e-05	0.00054	CcSEcCtD
Rasagiline—Asthenia—Donepezil—Alzheimer's disease	6.17e-05	0.00054	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	6.16e-05	0.00118	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PLD3—Alzheimer's disease	6.12e-05	0.00117	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—Alzheimer's disease	6.11e-05	0.00117	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP46A1—Alzheimer's disease	6.08e-05	0.00116	CbGpPWpGaD
Rasagiline—Pruritus—Donepezil—Alzheimer's disease	6.08e-05	0.000532	CcSEcCtD
Rasagiline—BCL2—IL-3 Signaling Pathway—AKT1—Alzheimer's disease	6.07e-05	0.00116	CbGpPWpGaD
Rasagiline—Urticaria—Rivastigmine—Alzheimer's disease	6.06e-05	0.000531	CcSEcCtD
Rasagiline—Abdominal pain—Rivastigmine—Alzheimer's disease	6.03e-05	0.000528	CcSEcCtD
Rasagiline—Body temperature increased—Rivastigmine—Alzheimer's disease	6.03e-05	0.000528	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP46A1—Alzheimer's disease	6e-05	0.00115	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CAV1—Alzheimer's disease	5.91e-05	0.00113	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—Alzheimer's disease	5.88e-05	0.00112	CbGpPWpGaD
Rasagiline—Diarrhoea—Donepezil—Alzheimer's disease	5.88e-05	0.000515	CcSEcCtD
Rasagiline—Hypersensitivity—Memantine—Alzheimer's disease	5.75e-05	0.000503	CcSEcCtD
Rasagiline—MAOB—Metabolism—CA4—Alzheimer's disease	5.73e-05	0.00109	CbGpPWpGaD
Rasagiline—Dizziness—Donepezil—Alzheimer's disease	5.68e-05	0.000497	CcSEcCtD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—Alzheimer's disease	5.67e-05	0.00108	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	5.67e-05	0.00108	CbGpPWpGaD
Rasagiline—Hypersensitivity—Rivastigmine—Alzheimer's disease	5.62e-05	0.000492	CcSEcCtD
Rasagiline—Asthenia—Memantine—Alzheimer's disease	5.6e-05	0.00049	CcSEcCtD
Rasagiline—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	5.53e-05	0.00106	CbGpPWpGaD
Rasagiline—Pruritus—Memantine—Alzheimer's disease	5.52e-05	0.000483	CcSEcCtD
Rasagiline—Asthenia—Rivastigmine—Alzheimer's disease	5.48e-05	0.000479	CcSEcCtD
Rasagiline—Vomiting—Donepezil—Alzheimer's disease	5.46e-05	0.000478	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MAPK8—Alzheimer's disease	5.44e-05	0.00104	CbGpPWpGaD
Rasagiline—Rash—Donepezil—Alzheimer's disease	5.42e-05	0.000474	CcSEcCtD
Rasagiline—Dermatitis—Donepezil—Alzheimer's disease	5.41e-05	0.000474	CcSEcCtD
Rasagiline—Pruritus—Rivastigmine—Alzheimer's disease	5.4e-05	0.000473	CcSEcCtD
Rasagiline—MAOB—Metabolism—GAPDHS—Alzheimer's disease	5.39e-05	0.00103	CbGpPWpGaD
Rasagiline—Headache—Donepezil—Alzheimer's disease	5.38e-05	0.000471	CcSEcCtD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—AKT1—Alzheimer's disease	5.38e-05	0.00103	CbGpPWpGaD
Rasagiline—Diarrhoea—Memantine—Alzheimer's disease	5.34e-05	0.000467	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—Alzheimer's disease	5.3e-05	0.00101	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TGFB1—Alzheimer's disease	5.28e-05	0.00101	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	5.27e-05	0.00101	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—AKT1—Alzheimer's disease	5.23e-05	0.001	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	5.23e-05	0.001	CbGpPWpGaD
Rasagiline—Diarrhoea—Rivastigmine—Alzheimer's disease	5.22e-05	0.000457	CcSEcCtD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	5.18e-05	0.000989	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—GSK3B—Alzheimer's disease	5.16e-05	0.000987	CbGpPWpGaD
Rasagiline—Dizziness—Memantine—Alzheimer's disease	5.16e-05	0.000452	CcSEcCtD
Rasagiline—MAOB—Metabolism—ATP5A1—Alzheimer's disease	5.11e-05	0.000975	CbGpPWpGaD
Rasagiline—Nausea—Donepezil—Alzheimer's disease	5.1e-05	0.000447	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.1e-05	0.000975	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	5.08e-05	0.00097	CbGpPWpGaD
Rasagiline—Dizziness—Rivastigmine—Alzheimer's disease	5.05e-05	0.000442	CcSEcCtD
Rasagiline—Vomiting—Memantine—Alzheimer's disease	4.96e-05	0.000434	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—IGF1—Alzheimer's disease	4.93e-05	0.000941	CbGpPWpGaD
Rasagiline—Rash—Memantine—Alzheimer's disease	4.92e-05	0.000431	CcSEcCtD
Rasagiline—Dermatitis—Memantine—Alzheimer's disease	4.92e-05	0.00043	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.91e-05	0.000937	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	4.9e-05	0.000936	CbGpPWpGaD
Rasagiline—Headache—Memantine—Alzheimer's disease	4.89e-05	0.000428	CcSEcCtD
Rasagiline—MAOB—Metabolism—PLD3—Alzheimer's disease	4.87e-05	0.00093	CbGpPWpGaD
Rasagiline—Vomiting—Rivastigmine—Alzheimer's disease	4.85e-05	0.000425	CcSEcCtD
Rasagiline—Rash—Rivastigmine—Alzheimer's disease	4.81e-05	0.000421	CcSEcCtD
Rasagiline—Dermatitis—Rivastigmine—Alzheimer's disease	4.81e-05	0.000421	CcSEcCtD
Rasagiline—Headache—Rivastigmine—Alzheimer's disease	4.78e-05	0.000419	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TGFB1—Alzheimer's disease	4.75e-05	0.000907	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—Alzheimer's disease	4.67e-05	0.000893	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD17B10—Alzheimer's disease	4.67e-05	0.000892	CbGpPWpGaD
Rasagiline—Nausea—Memantine—Alzheimer's disease	4.64e-05	0.000406	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—Alzheimer's disease	4.61e-05	0.00088	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	4.56e-05	0.000871	CbGpPWpGaD
Rasagiline—Nausea—Rivastigmine—Alzheimer's disease	4.53e-05	0.000397	CcSEcCtD
Rasagiline—MAOB—Metabolism—CYP46A1—Alzheimer's disease	4.49e-05	0.000859	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—Alzheimer's disease	4.46e-05	0.000853	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CTSB—Alzheimer's disease	4.45e-05	0.00085	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—Alzheimer's disease	4.38e-05	0.000837	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PPP3CA—Alzheimer's disease	4.36e-05	0.000833	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ND1—Alzheimer's disease	4.34e-05	0.000829	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIN1—Alzheimer's disease	4.28e-05	0.000818	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	4.22e-05	0.000806	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—GAB2—Alzheimer's disease	4.18e-05	0.000799	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—GSK3A—Alzheimer's disease	4.15e-05	0.000792	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CR1—Alzheimer's disease	4.13e-05	0.00079	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—MAPK8—Alzheimer's disease	4.1e-05	0.000784	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—APP—Alzheimer's disease	4.08e-05	0.000779	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.07e-05	0.000777	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CFH—Alzheimer's disease	4.07e-05	0.000777	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—Alzheimer's disease	3.95e-05	0.000754	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—Alzheimer's disease	3.91e-05	0.000747	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	3.87e-05	0.000739	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—Alzheimer's disease	3.79e-05	0.000725	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.78e-05	0.000722	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—Alzheimer's disease	3.67e-05	0.000701	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PVRL2—Alzheimer's disease	3.64e-05	0.000695	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	3.63e-05	0.000693	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—Alzheimer's disease	3.58e-05	0.000683	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	3.5e-05	0.000669	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MAPK8—Alzheimer's disease	3.49e-05	0.000666	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.47e-05	0.000663	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—S100B—Alzheimer's disease	3.31e-05	0.000633	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EIF2AK2—Alzheimer's disease	3.3e-05	0.000631	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—Alzheimer's disease	3.25e-05	0.00062	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—VEGFA—Alzheimer's disease	3.22e-05	0.000615	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.2e-05	0.000612	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—Alzheimer's disease	3.2e-05	0.000612	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—Alzheimer's disease	3.1e-05	0.000593	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	3.03e-05	0.000578	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.94e-05	0.000562	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	2.92e-05	0.000558	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MEF2C—Alzheimer's disease	2.9e-05	0.000554	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AGER—Alzheimer's disease	2.87e-05	0.000549	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—Alzheimer's disease	2.86e-05	0.000547	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PRKCG—Alzheimer's disease	2.84e-05	0.000543	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	2.83e-05	0.000541	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	2.82e-05	0.000538	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TPI1—Alzheimer's disease	2.8e-05	0.000534	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CHAT—Alzheimer's disease	2.8e-05	0.000534	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	2.75e-05	0.000525	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.75e-05	0.000525	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	2.7e-05	0.000515	CbGpPWpGaD
Rasagiline—BCL2—Immune System—INPP5D—Alzheimer's disease	2.69e-05	0.000515	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.66e-05	0.000508	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSB—Alzheimer's disease	2.59e-05	0.000495	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GAPDH—Alzheimer's disease	2.58e-05	0.000493	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSD—Alzheimer's disease	2.58e-05	0.000493	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PPP3CA—Alzheimer's disease	2.54e-05	0.000485	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	2.53e-05	0.000484	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTK2B—Alzheimer's disease	2.5e-05	0.000478	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—A2M—Alzheimer's disease	2.49e-05	0.000476	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.47e-05	0.000471	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CALM1—Alzheimer's disease	2.46e-05	0.00047	CbGpPWpGaD
Rasagiline—BCL2—Immune System—GAB2—Alzheimer's disease	2.44e-05	0.000465	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.42e-05	0.000463	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—Alzheimer's disease	2.42e-05	0.000462	CbGpPWpGaD
Rasagiline—BCL2—Immune System—GSK3A—Alzheimer's disease	2.41e-05	0.000461	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	2.38e-05	0.000456	CbGpPWpGaD
Rasagiline—BCL2—Immune System—APP—Alzheimer's disease	2.37e-05	0.000454	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	2.34e-05	0.000446	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	2.19e-05	0.000418	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ACHE—Alzheimer's disease	2.17e-05	0.000414	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—INPP5D—Alzheimer's disease	2.14e-05	0.00041	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—GSK3B—Alzheimer's disease	2.12e-05	0.000406	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CREB1—Alzheimer's disease	2.11e-05	0.000402	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—Alzheimer's disease	2.05e-05	0.000392	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.04e-05	0.000391	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	2.04e-05	0.00039	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	2.04e-05	0.00039	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS1—Alzheimer's disease	2.03e-05	0.000388	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ENO1—Alzheimer's disease	2.03e-05	0.000388	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP2D6—Alzheimer's disease	1.99e-05	0.000381	CbGpPWpGaD
Rasagiline—BCL2—Immune System—S100B—Alzheimer's disease	1.93e-05	0.000369	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—BCHE—Alzheimer's disease	1.89e-05	0.000361	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLCB1—Alzheimer's disease	1.78e-05	0.000341	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1A—Alzheimer's disease	1.75e-05	0.000334	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCA1—Alzheimer's disease	1.73e-05	0.00033	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MEF2C—Alzheimer's disease	1.69e-05	0.000323	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AGER—Alzheimer's disease	1.67e-05	0.00032	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRKCG—Alzheimer's disease	1.66e-05	0.000316	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	1.56e-05	0.000298	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARGC1A—Alzheimer's disease	1.49e-05	0.000285	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMOX1—Alzheimer's disease	1.48e-05	0.000283	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	1.45e-05	0.000278	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAPK8—Alzheimer's disease	1.43e-05	0.000274	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CALM1—Alzheimer's disease	1.43e-05	0.000274	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPL—Alzheimer's disease	1.36e-05	0.000259	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CA4—Alzheimer's disease	1.33e-05	0.000253	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.3e-05	0.000248	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.25e-05	0.000238	CbGpPWpGaD
Rasagiline—BCL2—Immune System—GSK3B—Alzheimer's disease	1.24e-05	0.000236	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CREB1—Alzheimer's disease	1.23e-05	0.000234	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—Alzheimer's disease	1.22e-05	0.000233	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.18e-05	0.000226	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CALM1—Alzheimer's disease	1.14e-05	0.000218	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOE—Alzheimer's disease	1.14e-05	0.000217	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.13e-05	0.000215	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.13e-05	0.000215	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CAV1—Alzheimer's disease	1.13e-05	0.000215	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.11e-05	0.000213	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.08e-05	0.000206	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.06e-05	0.000202	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.04e-05	0.000199	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ND1—Alzheimer's disease	1e-05	0.000192	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—Alzheimer's disease	9.9e-06	0.000189	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	9.82e-06	0.000188	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—INS—Alzheimer's disease	9.71e-06	0.000186	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—Alzheimer's disease	9.15e-06	0.000175	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—Alzheimer's disease	9.1e-06	0.000174	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	8.98e-06	0.000172	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NOS3—Alzheimer's disease	8.52e-06	0.000163	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—Alzheimer's disease	8.44e-06	0.000161	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAPK8—Alzheimer's disease	8.35e-06	0.000159	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—Alzheimer's disease	7.79e-06	0.000149	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.74e-06	0.000148	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.05e-06	0.000135	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TPI1—Alzheimer's disease	6.47e-06	0.000124	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CHAT—Alzheimer's disease	6.47e-06	0.000124	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MAOB—Alzheimer's disease	6.21e-06	0.000119	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	5.97e-06	0.000114	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.91e-06	0.000113	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.85e-06	0.000112	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—A2M—Alzheimer's disease	5.77e-06	0.00011	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—Alzheimer's disease	5.33e-06	0.000102	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.14e-06	9.83e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ACHE—Alzheimer's disease	5.02e-06	9.59e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	4.96e-06	9.48e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—Alzheimer's disease	4.92e-06	9.4e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.7e-06	8.99e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.7e-06	8.99e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.61e-06	8.81e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.37e-06	8.35e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.13e-06	7.88e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.05e-06	7.73e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4e-06	7.64e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—Alzheimer's disease	3.91e-06	7.48e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.45e-06	6.59e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.43e-06	6.56e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.14e-06	6e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.83e-06	5.4e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.64e-06	5.04e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.63e-06	5.03e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.61e-06	4.98e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.29e-06	4.38e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—INS—Alzheimer's disease	2.25e-06	4.29e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.97e-06	3.77e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.8e-06	3.44e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—Alzheimer's disease	9.06e-07	1.73e-05	CbGpPWpGaD
